Nearly a decade ago, a landmark trial of deep brain stimulation for depression failed to show efficacy. Now researchers are ...

Deep brain stimulation researchers at UCLA and UT Southwestern published a Nature study mapping, for the first time in living ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Scientists have pinpointed a brain network—and its distinctive electrical rhythm—that appears to drive the benefits of deep brain stimulation for Parkinson’s disease. The discovery could lead to more ...

Deep brain stimulation research published in Nature confirms for first time in human tissue that electrical pulses strengthen ...

An update to the traditional deep brain stimulation device enables adaptive pulses of electricity that help to lessen the symptoms of Parkinson’s disease and inform future research University of ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...

Inside a deep brain stimulation program at The Hospital for Sick Children (SickKids), researchers have discovered a brain signal that predicts when a child is about to lose attention—and that a brief, ...

Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...

The closed-loop neurostimulation market is estimated at USD 1.2 billion in 2025 and is projected to reach USD 6.0 billion by 2035, expanding at a CAGR of 17.5% during the forecast period 2026–2035.